NeoDynamics, focusing on breast cancer diagnostic, introduces next generation’s biopsy system in close collaboration with Etteplan
ETTEPLAN Press Release, June 2, 2021, at 10.15 a.m. EESTAfter 4 years of intensive work with Etteplan - its trusted engineering and design partner, NeoDynamics is now introducing a further development of the biobsy system; NeoNavia to the market. The system is intended for ultrasonic sampling and is built on an innovative patented pulse technology, designed to offer optimal needle control and maximum tissue yield for accurate diagnosis and individualized treatment of breast cancer. NeoDynamics AB is a Swedish Medical Technology Company dedicated to improve diagnosis and treatment of